Mental retardation and ADHD

被引:8
|
作者
Haessler, Frank [1 ]
Thome, Johannes [2 ]
机构
[1] Univ Rostock, Klin Psychiat Neurol Psychosomat & Psychotherapie, DE-18147 Rostock, Germany
[2] Univ Klinikum Rostock, Klin Psychiat & Psychotherapie, Rostock, Germany
来源
ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE | 2012年 / 40卷 / 02期
关键词
mental retardation; ADHD; epidemiology; etiology; psychopharmacotherapy; DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; INTELLECTUAL DISABILITY; METHYLPHENIDATE TREATMENT; PSYCHIATRIC-DISORDERS; GENE POLYMORPHISMS; CANDIDATE GENE; CHILDREN; ADOLESCENTS; PREVALENCE;
D O I
10.1024/1422-4917/a000155
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Mental retardation and ADHD Hyperactivity syndromes and disorders (ADHD and HKD) include the symptoms of overactivity, inattention, and impulsivity, which occur in many other mental disorders as well, including mental retardation (MR). It is not surprising that symptoms of ADHD occur significantly higher in children with learning disabilities. Dekker and Koot (2003) found a prevalence of 14.8% for ADHD in Dutch children attending special schools, and Emerson (2003) reported rates of 8.7% for HKD in children with global learning disability, representing a 10-fold increased risk compared to the prevalence of hyperactivity (0.9 %) in the general population sample. Yet only very few studies have been published concerning ADHD in children with mental retardation. Several features distinguish the diagnoses of ADHD and MR. In contrast to the limited knowledge about the differences and similarities of ADHD and MR, many studies considered stimulant medication as a pharmacological management strategy for children suffering from ADHD, MR, or both. According to these studies, psychostimulants may improve the target symptoms of hyperactivity, impulsivity, disinhibition, and inattention, albeit with caveats: ADHD symptoms in patients with MR may be less responsive to medical treatment than in patients without MR. Moreover, people with MR may be more susceptible to side effects.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [21] Mental retardation is dead: Long live mental retardation!
    Goode, D
    MENTAL RETARDATION, 2002, 40 (01): : 57 - 59
  • [22] Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy
    Kesic, A.
    Lakic, A.
    Dronjak, D.
    Stupar, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S420 - S421
  • [23] Mental retardation
    Ramey, SL
    CURRENT OPINION IN PSYCHIATRY, 1996, 9 (05) : 303 - 304
  • [24] MENTAL RETARDATION
    RICE, HK
    PSYCHOLOGICAL RECORD, 1966, 16 (02): : 208 - +
  • [25] EFFICACY OF METHYLPHENIDATE AND BEHAVIORAL INTERVENTION ON CLASSROOM-BEHAVIOR IN CHILDREN WITH ADHD AND MENTAL-RETARDATION
    JOHNSON, CR
    HANDEN, BL
    LUBETSKY, MJ
    SACCO, KA
    BEHAVIOR MODIFICATION, 1994, 18 (04) : 470 - 487
  • [26] MENTAL RETARDATION
    GIBSON, J
    BRITISH MEDICAL JOURNAL, 1963, (536): : 1201 - &
  • [27] Mental retardation
    Melfsen, S
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2000, 28 (04): : 300 - 300
  • [28] MENTAL RETARDATION
    CRAUSMAN, B
    PSYCHOSOMATICS, 1966, 7 (01) : 19 - 20
  • [29] Mental retardation
    Madhulika Kabra
    Sheffali Gulati
    The Indian Journal of Pediatrics, 2003, 70 (2) : 153 - 158
  • [30] MENTAL RETARDATION
    SYMONDS, H
    LANCET, 1955, 2 (JUL9): : 91 - 91